全文获取类型
收费全文 | 3013篇 |
免费 | 171篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 132篇 |
妇产科学 | 31篇 |
基础医学 | 372篇 |
口腔科学 | 46篇 |
临床医学 | 289篇 |
内科学 | 581篇 |
皮肤病学 | 48篇 |
神经病学 | 431篇 |
特种医学 | 84篇 |
外科学 | 464篇 |
综合类 | 55篇 |
一般理论 | 4篇 |
预防医学 | 167篇 |
眼科学 | 51篇 |
药学 | 145篇 |
中国医学 | 15篇 |
肿瘤学 | 248篇 |
出版年
2023年 | 23篇 |
2022年 | 43篇 |
2021年 | 86篇 |
2020年 | 45篇 |
2019年 | 85篇 |
2018年 | 104篇 |
2017年 | 60篇 |
2016年 | 74篇 |
2015年 | 71篇 |
2014年 | 130篇 |
2013年 | 155篇 |
2012年 | 210篇 |
2011年 | 213篇 |
2010年 | 123篇 |
2009年 | 103篇 |
2008年 | 168篇 |
2007年 | 158篇 |
2006年 | 167篇 |
2005年 | 144篇 |
2004年 | 142篇 |
2003年 | 132篇 |
2002年 | 113篇 |
2001年 | 72篇 |
2000年 | 48篇 |
1999年 | 67篇 |
1998年 | 24篇 |
1997年 | 30篇 |
1996年 | 17篇 |
1995年 | 16篇 |
1994年 | 25篇 |
1993年 | 13篇 |
1992年 | 32篇 |
1991年 | 18篇 |
1990年 | 18篇 |
1989年 | 18篇 |
1988年 | 17篇 |
1987年 | 15篇 |
1986年 | 24篇 |
1985年 | 30篇 |
1984年 | 13篇 |
1983年 | 14篇 |
1982年 | 10篇 |
1981年 | 8篇 |
1980年 | 11篇 |
1979年 | 12篇 |
1978年 | 9篇 |
1973年 | 8篇 |
1972年 | 7篇 |
1970年 | 7篇 |
1966年 | 9篇 |
排序方式: 共有3188条查询结果,搜索用时 15 毫秒
41.
42.
This report describes a case of manic symptoms induced by olanzapine in an 85-year-old female with a 3 year history of delusional disorder. She was treated in the past with trifluoperazine and risperidone. Symptoms were severe enough to require detention in hospital. Florid manic symptoms resolved two weeks after stopping olanzapine while only using 1 mg of haloperidol as required. 相似文献
43.
44.
45.
46.
Bal Kishan Gupta Kailash Chandra Nayak Sunil Kumar Surendra Kumar Anjli Gupta Parul Prakash 《急性病杂志》2012,1(2):100-106
ObjectiveTo report a comparative clinical and histopathological study on oliguric and non-oliguric acute renal failure (ARF) in malaria.Method311 consecutive cases of malaria out of which 74 (23.79%) had ARF as per WHO criteria were conducted. Mean age was 32.58 (range 15–60 years) and male: female was 2:1.ResultMost of the cases developed ARF within 10 d of onset. 18 cases (11 falciparum, 2 mixed, 5 vivax) presented with oliguric and 56 (41 falciparum, 6 mixed, 9 vivax) with non-oliguric renal failure. Associated major manifestations were jaundice (75.68%), cerebral malaria (41.89%), bleeding manifestations (32.43%), severe anemia (27.03%), hypotension (25.68%), multi-organ failure (18.92%), severe thrombocytopenia (12.16%), and ARDS (8.11%). Kidney biopsy (n=20) showed acute tubular necrosis (n=7), Mesangioproliferative glomerulonephritis (n=4) or both (n=9). Hemodialysis was done in 8 cases of oliguric renal failure out of which 4 survived (average no. of session 2.9).ConclusionMost of the cases recovered within 3 weeks. Total mortality was 28.38% (n=21) and mortality was more in oliguric renal failure (72.22%) as compare to non-oliguric renal failure (14.29%). 相似文献
47.
Amit Goel Dharmendra Singh Bhadauria Anupma Kaul Narayan Prasad Amit Gupta Raj Kumar Sharma Praveer Rai Rakesh Aggarwal 《Indian journal of gastroenterology》2017,36(2):137-140
In recent past, direct-acting anti-viral drugs (DAAs) have become the standard of care for the treatment of hepatitis C virus (HCV) infection. However, the experience with the use of these drugs in Indian renal transplant recipients is limited. We retrospectively reviewed our experience with DAA-based treatment for HCV infection in such patients. Between April 2015 and December 2016, six adults (median age 41 [range 34–52] years, male 5; GT1 2, GT3 3, and GT4 1; including three with prior failed interferon-based treatment) had received genotype-guided, DAA-based anti-HCV treatment 1 to 158 (median 15) months after renal transplantation. Of them, four completed the planned 24-week treatment without any significant adverse event. One of them had increase in serum creatinine after 16 weeks of treatment with sofosbuvir and daclatasvir, with acute interstitial nephritis on kidney biopsy; his renal function improved on stopping the drugs. The other patient had preexisting mild renal dysfunction, which worsened after 8 weeks of sofosbuvir-ledipasvir treatment; this did not reverse on stopping treatment. All the six patients achieved undetectable HCV RNA after 4 weeks of treatment and also achieved sustained virologic response, i.e. lack of detectable HCV RNA in serum 12 weeks after stopping treatment. Overall, DAA-based treatment was effective in treating HCV infection in our renal transplant recipients; however, caution and monitoring of renal function during such treatment is advisable in patients who have additional factors that predispose to renal injury. 相似文献
48.
Evaluation of beta defensin 2 production by chicken heterophils using direct MALDI mass spectrometry
Lakshmi Kannan Rohana Liyanage Jackson O. Lay Jr. Narayan C. Rath 《Molecular immunology》2009,46(15):3151-3156
Beta defensins (BD) are cysteine rich, cationic antimicrobial peptides (AMP) produced mainly by epithelial and myeloid cells such as neutrophils. In birds, the neutrophil equivalent heterophils produce avian beta defensins (AvBD) of which AvBD2 is the major isoform. Heterophils recognize pathogens or their derived products through a series of pattern recognition receptors called toll-like receptors (TLR) leading to their antimicrobial activities. This work is the first report of TLR modulation of AvBD2 expression in chickens. To measure the effect of TLR activation on AvBD2 production, the heterophils were cultured with different TLR agonists for 6 h. Modulation of AvBD2 levels by TLR activation was measured using direct MALDI mass spectrometry without stable isotopic labeling or chromatographic separation. Chemical modification of the conditioned media was performed using reduction/alkylation with dithiothreitol/iodoacetamide to distinguish TLR treated AvBD2 (reduced/alkylated) from controls (non-reduced). Changes in corrected ion intensity ratios were assumed to reflect AvBD2 modulation in heterophils upon activation with different TLR agonists. In general, TLR agonists increased AvBD2 production with LPS showing the greatest induction and CpG-ODN showing little or no effect. These data show that the direct MALDI-MS coupled with reduction/alkylation may provide a rapid relative quantitative approach to the measurement of agonist-induced differential expression of AvBD2. 相似文献
49.
50.